Clinical Trials Directory

Trials / Completed

CompletedNCT01926353

Polyacrylate Polyalcohol Copolymer for Vesicoureteral Reflux

Tissue Bulking Agent -Polyacrylate Polyalcohol Copolymer for Endoscopic Correction of Vesicoureteral Reflux in Children: A Comparative Study

Status
Completed
Phase
Study type
Observational
Enrollment
25 (actual)
Sponsor
St. Luke's Medical Center, Philippines · Academic / Other
Sex
All
Age
1 Year – 5 Years
Healthy volunteers
Not accepted

Summary

Endoscopic correction of VUR has gained its popularity due to its less invasiveness, associated low morbidity and short hospital stay. Although short term follow-up had justified their efficacy; however, long term recurrence and complications following endoscopic correction were also being reported in the literatures (6). Currently, there are insufficient evidences on the efficacy and safety of biocompatible tissue augmenting materials used for endoscopic correction of VUR; particularly on the new tissue bulking agents. (6) Polyacrylate polyalcohol copolymer (PPC)-Vantris ® (Promedon, Cordoba, Argentina) is the newest tissue augmenting biocompatible Acrylics used for endoscopic correction of VUR.

Conditions

Timeline

Start date
2013-07-01
Primary completion
2014-02-01
Completion
2014-02-01
First posted
2013-08-20
Last updated
2015-04-07

Locations

1 site across 1 country: Philippines

Source: ClinicalTrials.gov record NCT01926353. Inclusion in this directory is not an endorsement.